3-Bromo-4-hydroxybenzaldehyde - CAS 2973-78-6
Catalog: |
BB020298 |
Product Name: |
3-Bromo-4-hydroxybenzaldehyde |
CAS: |
2973-78-6 |
Synonyms: |
3-bromo-4-hydroxybenzaldehyde |
IUPAC Name: | 3-bromo-4-hydroxybenzaldehyde |
Description: | 3-Bromo-4-hydroxybenzaldehyde acts as a reagent in the synthesis and examination of the microbiostatic properties of phenols and related compounds against pathogenic bacteria and fungi. Anti-bacterial and anti-protozoal compositions containing bromophenol-based compounds for the treatment and prevention of fish diseases like Scuticociliatosis and Edwardsiella tarda. |
Molecular Weight: | 201.02 |
Molecular Formula: | C7H5BrO2 |
Canonical SMILES: | C1=CC(=C(C=C1C=O)Br)O |
InChI: | InChI=1S/C7H5BrO2/c8-6-3-5(4-9)1-2-7(6)10/h1-4,10H |
InChI Key: | UOTMHAOCAJROQF-UHFFFAOYSA-N |
Boiling Point: | 261.3 °C at 760 mmHg |
Melting Point: | 130-135 °C |
Purity: | 95 % |
Density: | 1.737 g/cm3 |
Appearance: | Colorless or light yellow crystal |
MDL: | MFCD00017348 |
LogP: | 1.96720 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-111548286-A | PSA derivative with HDAC3 inhibitory activity and application thereof | 20200513 |
CN-111362784-A | Method for preparing ethyl vanillin from sassafras oil | 20200424 |
CN-111303030-A | Application of acrididone compound in preparation of antidiabetic drugs | 20200408 |
CN-111303030-B | Application of acrididone compound in preparation of antidiabetic drugs | 20200408 |
WO-2021204197-A1 | Application of acridinedione compound in preparation of anti-diabetic drugs | 20200408 |
PMID | Publication Date | Title | Journal |
22137848 | 20120101 | Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as platelet aggregation inhibitors | Bioorganic & medicinal chemistry letters |
21127464 | 20101202 | Synthesis of the marine bromotyrosine psammaplin F and crystal structure of a psammaplin A analogue | Molecules (Basel, Switzerland) |
Complexity: | 127 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 199.94729 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 199.94729 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 37.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
-
[75629-57-1]
Oncrasin-1
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
-
[873651-92-4]
5-Amino-2-(hydroxymethyl)pyridine
-
[84030-20-6]
1,3,4,6,7,8-Hexahydro-1-methyl-2H-pyrimido[1,2-a]pyrimidine
-
[80935-77-9]
2,6-Naphthyridin-1(2H)-one
-
[6138-90-5]
Geranyl bromide
INDUSTRY LEADERS TRUST OUR PRODUCTS